IIM
OVID icon

INTECH Investment Management’s Ovid Therapeutics OVID Stock Holding History

INTECH Investment Management’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77.5K Buy
+28,826
New +$74.4K ﹤0.01% 1986
2025
Q2 		– Sell
-44,010
Closed -$13.7K – 2612
2025
Q1 		$13.7K Buy
44,010
+20,286
+86% +$12.5K ﹤0.01% 2512
2024
Q4 		$22.2K Buy
+23,724
New +$26.5K ﹤0.01% 2370

Other funds holding OVID

JT
Jupiter Topco New York $245B AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

INTECH Investment Management's OVID Position: Q2 2026 in Review

INTECH Investment Management opened a new position in Ovid Therapeutics (OVID) in Q2 2026: 28,826 shares worth $77.5K. The stake represents ﹤0.01% of the portfolio and ranks #1986 among its holdings. This is a return to the name: INTECH Investment Management previously reported a position in OVID as recently as Q1 2025.

INTECH Investment Management first reported a position in OVID in Q4 2024 and has held it in 3 quarters since. 130 funds tracked by Wall St. Rank hold OVID as of Q2 2026.

  • INTECH Investment Management held 28,826 shares of Ovid Therapeutics worth $77.5K as of Q2 2026.
  • Ovid Therapeutics was a new INTECH Investment Management position in Q2 2026.
  • Ovid Therapeutics made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1986 holding.
  • INTECH Investment Management first reported a position in Ovid Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • 130 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.